BSE filing, NSE: TTIENT. Summary written from the filing by ALFA Finder's alert engine.
TTI Enterprise Ltd: key numbers
- Share price
- ₹7.10
- Market cap
- ₹18.04 Cr
- Revenue (annual)
- ₹2.46 Cr
- Net profit (annual)
- ₹-1.41 Cr
- P/E (TTM)
- -11.9×Sector 19.7×
- Promoter holding
- 18.57%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TTI Enterprise Ltd
All →TTI Enterprise Annual General Meeting
TTI Enterprise Limited conducted its 45th AGM, where shareholders considered resolutions for loan approvals up to Rs. 1000 Crore and material related-party transactions.
TTI Enterprise Annual General Meeting
TTI Enterprise Limited will hold its 45th Annual General Meeting on September 28, 2026. The meeting will be conducted via video conferencing to adopt FY26 financial statements.
TTI Enterprise Other Announcement
TTI Enterprise Limited has completed the transition of its Registrar and Share Transfer Agent (RTA) to Purva Sharegistry (India) Private Limited, effective August 28, 2026.
TTI Enterprise Board Meeting Outcome
TTI Enterprise announced board approval to set borrowing limits and investment authority up to ₹1,000 crore each. It also convened the 45th AGM for September 2026.
TTI Enterprise Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 25.0% YoY
TTI Enterprise Ltd reported revenue from operations of ₹0.6 Cr (-14.3% YoY) and net profit of ₹0.3 Cr (-25.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · -25.0% YoY
TTI Enterprise Board Meeting Date
TTI Enterprise Ltd will meet on August 13, 2026, to consider and approve the un-audited standalone financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.